Ultrasmall Manganese Ferrites for In Vivo Catalase Mimicking Activity and Multimodal Bioimaging

Manganese ferrite nanoparticles display interesting features in bioimaging and catalytic therapies. They have been recently used in theranostics as contrast agents in magnetic resonance imaging (MRI), and as catalase‐mimicking nanozymes for hypoxia alleviation. These promising applications encourage...

Full description

Saved in:
Bibliographic Details
Published inSmall (Weinheim an der Bergstrasse, Germany) Vol. 18; no. 16; pp. e2106570 - n/a
Main Authors Carregal‐Romero, Susana, Miguel‐Coello, Ana Beatriz, Martínez‐Parra, Lydia, Martí‐Mateo, Yolanda, Hernansanz‐Agustín, Pablo, Fernández‐Afonso, Yilian, Plaza‐García, Sandra, Gutiérrez, Lucía, Muñoz‐Hernández, María del Mar, Carrillo‐Romero, Juliana, Piñol‐Cancer, Marina, Lecante, Pierre, Blasco‐Iturri, Zuriñe, Fadón, Lucía, Almansa‐García, Ana C., Möller, Marco, Otaegui, Dorleta, Enríquez, Jose Antonio, Groult, Hugo, Ruíz‐Cabello, Jesús
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.04.2022
Wiley-VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Manganese ferrite nanoparticles display interesting features in bioimaging and catalytic therapies. They have been recently used in theranostics as contrast agents in magnetic resonance imaging (MRI), and as catalase‐mimicking nanozymes for hypoxia alleviation. These promising applications encourage the development of novel synthetic procedures to enhance the bioimaging and catalytic properties of these nanomaterials simultaneously. Herein, a cost‐efficient synthetic microwave method is developed to manufacture ultrasmall manganese ferrite nanoparticles as advanced multimodal contrast agents in MRI and positron emission tomography (PET), and improved nanozymes. Such a synthetic method allows doping ferrites with Mn in a wide stoichiometric range (MnxFe3‐xO4, 0.1 ≤ x ≤ 2.4), affording a library of nanoparticles with different magnetic relaxivities and catalytic properties. These tuned magnetic properties give rise to either positive or dual‐mode MRI contrast agents. On the other hand, higher levels of Mn doping enhance the catalytic efficiency of the resulting nanozymes. Finally, through their intracellular catalase‐mimicking activity, these ultrasmall manganese ferrite nanoparticles induce an unprecedented tumor growth inhibition in a breast cancer murine model. All of these results show the robust characteristics of these nanoparticles for nanobiotechnological applications. Ultrasmall manganese ferrite nanoparticles with variable Mn doping can be produced through a microwave‐assisted one‐pot method. The versatility of this synthetic method allows obtaining a library of different nanoparticles with advanced features in multimodal imaging (MRI/PET/CT) and catalase‐mimicking activity for nanobiotechnological applications in vitro and in vivo.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1613-6810
1613-6829
DOI:10.1002/smll.202106570